跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 60,563 条关于
“POETYK PSO-1”
全部
60,563
临床试验
36,334
药物
7,591
机构
1,410
资讯
15,228
9个月前
Deucravacitinib Shows Efficacy in Psoriasis Patients Who Failed Apremilast Treatment
去年
Novel Oral Psoriasis Therapies Show Promise: TYK2 Inhibitors Lead Breakthrough Advances
去年
Deucravacitinib Demonstrates Long-Term Efficacy and Safety in Psoriasis Treatment
去年
Bristol Myers Squibb Announces Positive Data for Sotyktu in Moderate to Severe Psoriasis
去年
Sotyktu Meets Primary Endpoints in Phase 3 Psoriatic Arthritis Trials
去年
JAK Inhibitor Pipeline Shows Promise for Autoimmune and Inflammatory Diseases
前天
FDA Accepts Takeda's Zasocitinib NDA Under Priority Review for Moderate-to-Severe Plaque Psoriasis
去年
JNJ-2113 Shows Promising Phase 3 Results for Plaque Psoriasis
10个月前
Bristol Myers Squibb Reports Sustained Efficacy of Sotyktu in Psoriatic Arthritis and Lupus Through Extended Follow-up
18天前
Lilly's Taltz Plus Zepbound Shows Durable One-Year Benefits in Psoriatic Disease and Obesity
第 1 页,共 1523 页
上一页
下一页